Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Mitochondrial metabolism directs stemness and differentiation in P19 embryonal carcinoma stem cells.

Vega-Naredo I, Loureiro R, Mesquita KA, Barbosa IA, Tavares LC, Branco AF, Erickson JR, Holy J, Perkins EL, Carvalho RA, Oliveira PJ.

Cell Death Differ. 2014 Oct;21(10):1560-74. doi: 10.1038/cdd.2014.66. Epub 2014 May 16.

2.

Dynamic mitochondrial changes during differentiation of P19 embryonic carcinoma cells into cardiomyocytes.

Jin J, Xuan QK, Zhou LJ, Shi CM, Song GX, Sheng YH, Qian LM.

Mol Med Rep. 2014 Aug;10(2):761-6. doi: 10.3892/mmr.2014.2315. Epub 2014 Jun 10.

PMID:
24920049
3.

Melatonin antiproliferative effects require active mitochondrial function in embryonal carcinoma cells.

Loureiro R, Magalhães-Novais S, Mesquita KA, Baldeiras I, Sousa IS, Tavares LC, Barbosa IA, Oliveira PJ, Vega-Naredo I.

Oncotarget. 2015 Jul 10;6(19):17081-96.

4.

UCP2 regulates energy metabolism and differentiation potential of human pluripotent stem cells.

Zhang J, Khvorostov I, Hong JS, Oktay Y, Vergnes L, Nuebel E, Wahjudi PN, Setoguchi K, Wang G, Do A, Jung HJ, McCaffery JM, Kurland IJ, Reue K, Lee WN, Koehler CM, Teitell MA.

EMBO J. 2011 Nov 15;30(24):4860-73. doi: 10.1038/emboj.2011.401. Erratum in: EMBO J. 2016 Apr 15;35(8):899.

5.

Metabolic reprogramming orchestrates cancer stem cell properties in nasopharyngeal carcinoma.

Shen YA, Wang CY, Hsieh YT, Chen YJ, Wei YH.

Cell Cycle. 2015;14(1):86-98. doi: 10.4161/15384101.2014.974419.

6.

Mitochondrial and energy metabolism-related properties as novel indicators of lung cancer stem cells.

Ye XQ, Li Q, Wang GH, Sun FF, Huang GJ, Bian XW, Yu SC, Qian GS.

Int J Cancer. 2011 Aug 15;129(4):820-31. doi: 10.1002/ijc.25944. Epub 2011 Apr 25.

7.

Energy metabolism in human pluripotent stem cells and their differentiated counterparts.

Varum S, Rodrigues AS, Moura MB, Momcilovic O, Easley CA 4th, Ramalho-Santos J, Van Houten B, Schatten G.

PLoS One. 2011;6(6):e20914. doi: 10.1371/journal.pone.0020914. Epub 2011 Jun 17.

8.

Dual-targeting of aberrant glucose metabolism in glioblastoma.

Shen H, Decollogne S, Dilda PJ, Hau E, Chung SA, Luk PP, Hogg PJ, McDonald KL.

J Exp Clin Cancer Res. 2015 Feb 5;34:14. doi: 10.1186/s13046-015-0130-0.

9.

Dichloroacetate, the Pyruvate Dehydrogenase Complex and the Modulation of mESC Pluripotency.

Rodrigues AS, Correia M, Gomes A, Pereira SL, Perestrelo T, Sousa MI, Ramalho-Santos J.

PLoS One. 2015 Jul 6;10(7):e0131663. doi: 10.1371/journal.pone.0131663. eCollection 2015.

10.

Connecting Mitochondria, Metabolism, and Stem Cell Fate.

Wanet A, Arnould T, Najimi M, Renard P.

Stem Cells Dev. 2015 Sep 1;24(17):1957-71. doi: 10.1089/scd.2015.0117. Epub 2015 Jul 2. Review.

11.

Distinct profiles of human embryonic stem cell metabolism and mitochondria identified by oxygen.

Lees JG, Rathjen J, Sheedy JR, Gardner DK, Harvey AJ.

Reproduction. 2015 Oct;150(4):367-82. doi: 10.1530/REP-14-0633. Epub 2015 Jul 9.

12.

Foxm1 transcription factor is required for maintenance of pluripotency of P19 embryonal carcinoma cells.

Xie Z, Tan G, Ding M, Dong D, Chen T, Meng X, Huang X, Tan Y.

Nucleic Acids Res. 2010 Dec;38(22):8027-38. doi: 10.1093/nar/gkq715. Epub 2010 Aug 11.

13.

Selection and properties for the recognition of P19 embryonic carcinoma stem cells.

Morita Y, Mamiya K, Yamamura S, Tamiya E.

Biotechnol Prog. 2006 Jul-Aug;22(4):974-8.

PMID:
16889372
14.

Comparison of spheroids formed by rat glioma stem cells and neural stem cells reveals differences in glucose metabolism and promising therapeutic applications.

Morfouace M, Lalier L, Bahut M, Bonnamain V, Naveilhan P, Guette C, Oliver L, Gueguen N, Reynier P, Vallette FM.

J Biol Chem. 2012 Sep 28;287(40):33664-74. Epub 2012 Jul 10.

15.

FOXM1-Induced PRX3 Regulates Stemness and Survival of Colon Cancer Cells via Maintenance of Mitochondrial Function.

Song IS, Jeong YJ, Jeong SH, Heo HJ, Kim HK, Bae KB, Park YH, Kim SU, Kim JM, Kim N, Ko KS, Rhee BD, Han J.

Gastroenterology. 2015 Oct;149(4):1006-16.e9. doi: 10.1053/j.gastro.2015.06.007. Epub 2015 Jun 17.

PMID:
26091938
16.

Mitochondrial mass, a new metabolic biomarker for stem-like cancer cells: Understanding WNT/FGF-driven anabolic signaling.

Lamb R, Bonuccelli G, Ozsvári B, Peiris-Pagès M, Fiorillo M, Smith DL, Bevilacqua G, Mazzanti CM, McDonnell LA, Naccarato AG, Chiu M, Wynne L, Martinez-Outschoorn UE, Sotgia F, Lisanti MP.

Oncotarget. 2015 Oct 13;6(31):30453-71. doi: 10.18632/oncotarget.5852.

17.

Heterochromatin protein 1γ overexpression in P19 embryonal carcinoma cells elicits spontaneous differentiation into the three germ layers.

Morikawa K, Ikeda N, Hisatome I, Shirayoshi Y.

Biochem Biophys Res Commun. 2013 Feb 8;431(2):225-31. doi: 10.1016/j.bbrc.2012.12.128. Epub 2013 Jan 9.

PMID:
23313480
18.

Dual modulation of the mitochondrial permeability transition pore and redox signaling synergistically promotes cardiomyocyte differentiation from pluripotent stem cells.

Cho SW, Park JS, Heo HJ, Park SW, Song S, Kim I, Han YM, Yamashita JK, Youm JB, Han J, Koh GY.

J Am Heart Assoc. 2014 Mar 13;3(2):e000693. doi: 10.1161/JAHA.113.000693.

19.

Overexpression of FABP3 promotes apoptosis through inducing mitochondrial impairment in embryonic cancer cells.

Song GX, Shen YH, Liu YQ, Sun W, Miao LP, Zhou LJ, Liu HL, Yang R, Kong XQ, Cao KJ, Qian LM, Sheng YH.

J Cell Biochem. 2012 Dec;113(12):3701-8. doi: 10.1002/jcb.24243.

PMID:
22753283
20.

Metabolic Modulation of Clear-cell Renal Cell Carcinoma with Dichloroacetate, an Inhibitor of Pyruvate Dehydrogenase Kinase.

Kinnaird A, Dromparis P, Saleme B, Gurtu V, Watson K, Paulin R, Zervopoulos S, Stenson T, Sutendra G, Pink DB, Carmine-Simmen K, Moore R, Lewis JD, Michelakis ED.

Eur Urol. 2016 Apr;69(4):734-44. doi: 10.1016/j.eururo.2015.09.014. Epub 2016 Feb 18.

PMID:
26433571

Supplemental Content

Support Center